Company Filing History:
Years Active: 2004-2011
Title: Joseph Tardio: Innovator in Pharmaceutical Compositions
Introduction
Joseph Tardio is a notable inventor based in St. Louis, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that inhibit lipases. With a total of 2 patents, Tardio's work has the potential to impact the treatment of various health conditions.
Latest Patents
Tardio's latest patents include innovative pharmaceutical compositions. The first patent focuses on pharmaceutical compositions containing lipase inhibitors. This composition comprises at least one inhibitor of lipases, preferably targeting gastrointestinal and pancreatic lipases, such as orlistat, along with at least one surfactant and one dispersant. The second patent involves lipase inhibiting compositions that contain at least one inhibitor of lipases and at least one fatty acid ester of polyol. In this formulation, the fatty acid ester has a melting point above body temperature, and the polyols are selected from sugars, sugar derivatives, and their mixtures.
Career Highlights
Joseph Tardio is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this organization has allowed him to focus on developing innovative solutions that address critical health issues.
Collaborations
Throughout his career, Tardio has collaborated with esteemed colleagues, including Passchier Christiaan De Smidt and Paul Hadvary. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Joseph Tardio is a prominent inventor whose work in pharmaceutical compositions has the potential to make a significant impact in the medical field. His innovative patents reflect his dedication to improving health outcomes through scientific advancements.